期刊文献+

Hsp90在胰腺癌组织中表达升高及其临床病理意义 被引量:4

Increased expression of Hsp90 in pancreatic cancer and its clinical pathological significance
下载PDF
导出
摘要 目的分析热休克蛋白90(Hsp90)在胰腺癌组织中的表达水平与肿瘤发生、发展和转移的关系及其对预后的影响。方法用市售组织芯片,通过免疫组化法测定2009年1月至2013年8月期间病理确诊为胰腺癌的63例患者癌标本和癌旁组织中的Hsp90表达,用ANOVA或者t检验分析Hsp90表达水平与患者相关临床病理指标之间的关系。结果胰腺癌组织中Hsp90的表达量显著高于癌旁组织,与肿瘤的病理分级、淋巴结转移、临床分期、TNM分期有关(P<0.05)。结论胰腺癌组织中高表达Hsp90与胰腺癌的高侵袭、高转移能力密切相关,高表达的Hsp90可能作为胰腺癌的预后指标以提示患者预后差。 Objective To explore the expression and meaning of heat shock protein 90(Hsp90)in pancreatic cancer and its correlation with the occurrence,development and metastasis of the tumor tissues and its influence on prognosis.Methods Via immunohistochemical staining,this study used the commercial tissue chip to determine the expression of Hsp90 in 63 pancreatic cancer resection specimens and their para-cancerous counterparts,which were pathologically confirmed from January 2009 to August 2013.We also analyzed the correlation with patient s clinical parameters by using one-way ANOVA or t test.Results Hsp90 expression in pancreatic cancer tissues was significantly higher than tissue adjacent to carcinoma,and it was associated with histological grade,lymph node metastasis,clinical and TNM phase of pancreatic cancer(P<0.05).Conclusions Hsp90 is highly expressed in pancreatic cancer tissues,and its expression is associated with invasion and metastasis of pancreatic cancer.Therefore,Hsp90 may serves as a prognostic indicator of pancreatic cancer while its high expression may represent poor prognosis of pancreatic cancer patients.
作者 刘俊雅 范姝婕 黄薇 杨楠 刘雁勇 LIU Junya;FAN Shujie;HUANG Wei;YANG Nan;LIU Yanyong(Dept.of Pharmacology,Institute of Basic Medical Sciences CAMS,School of Basic Medicine PUMC,Beijing 100005,China)
出处 《基础医学与临床》 CSCD 2018年第4期497-501,共5页 Basic and Clinical Medicine
基金 北京市自然科学基金(7172134) 协和青年科研基金与中央高校基本科研业务费专项基金(3332015113 2017350002) 中国医学科学院医学与健康科技创新工程(2016-I2M-3-004)
关键词 胰腺癌 热休克蛋白Hsp90 免疫组化 pancreatic cancer heat shock protein Hsp90 immunohistochemistry
  • 相关文献

参考文献2

二级参考文献25

  • 1Andrulis M,Chatlerjee M,Jain S,et al.Heat shock protein 902/βare overexpressed in multiple myeloma cells and critically contribute to survival.Verh Dtsch Ges Pathol,2007;91(1):330-337.
  • 2Khong T,Spencer A.Targeting HSP 90 induces apoptosis and inhibits critical survival and proliferation pathways in multiple myeloma.Mol Cancer Ther,2011;10(10):1909-1917.
  • 3Giménez Ortiz A,Montalar Salcedo J.Heat shock proteins as targets in oncology.Clin Transl Oncol,2010;12(3):166-173.
  • 4Munshi NC,Anderson KC.New Strategies in the Treatment of Multiple Myeloma.Clin Cancer Res,2013;19(13):3337-3344.
  • 5Ludwig H,Sonneveld P.Disease control in patients with relapsed and/or refractory multiple myeloma:what is the optimal duration of therapy?.Leuk Res,2012;36(Suppl 1):S27-34.
  • 6Li J,Buchner J.Structure,function and regulation of the hsp90machinery.Biomed J,2013;36(3):106-117.
  • 7Duus J,Bahar HI,Venkataraman G,et al.Analysis of expression of heat shock protein-90(HSP90)and the effects of HSP90 inhibitor(17-AAG)in multiple myeloma.Leuk Lymphoma,2006;47(7):1369-1378.
  • 8Mitsiades CS,Mitsiades NS,McMullan CJ,et al.Antimyeloma activity of heat shock protein-90 inhibition.Blood,2006;107(3):1092-1100.
  • 9Richardson PG,Mitsiades CS,Laubach JP,et al.Inhibition of heat shock protein 90(HSP90)as a therapeutic strategy for the treatment of myeloma and other cancers.Br J Haematol,2011;152(4):367-379.
  • 10Chatterjee M,Jain S,Stühmer T,et al.STAT3 and MAPK signaling maintain overexpression of heat shock proteins 90alpha and beta in multiple myeloma cells,which critically contribute to tumor-cell survival.Blood,2007;109(2):720-728.

共引文献13

同被引文献24

引证文献4

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部